Seq #142 Friday, 10 March 2006

2:00 PM-3:00 PM Dolphin Hotel Pacific Hall, Poster
Periodontal Therapy and Prevention
 
1143  Antibiotic Treatment of Chronic Periodontitis Reduces Serum Inflammatory Markers
H. HASTURK1, J. DEADY1, E. BLACK1, M.L. WARBINGTON1, A. KANTARCI1, J.M. GOODSON2, and T.E. VAN DYKE1, 1Boston University, MA, USA, 2Forsyth Institute, Boston, MA, USA
1144  Effects of Periodontal Therapy on Local and Systemic Inflammatory Biomarkers
O.I. CARNU, J. FARRELL, R. TENZLER, R. ORINGER, and M.E. RYAN, Stony Brook University, NY, USA
1145  Subset Analysis by Smoking Status With Arestin® in Periodontitis Therapy
S. GROSSI, State University of New York - SUNY - Buffalo, USA, J.M. GOODSON, Forsyth Institute, Boston, MA, USA, P. BLAND, University of Tennessee, College of Dentistry, Memphis, USA, J.C. GUNSOLLEY, University of Maryland Dental School, Baltimore, USA, and J. OTOMO-CORGEL, Greater Los Angeles VA Health Care System, CA, USA
1146  Effects of minocycline on oral multi-species biofilms
S. DOUCETTE1, K. RUGGIERO1, A. ABERNETHY1, C. LU1, E. KANASI1, A. TANNER1, J.R. LAWTER2, J.M. GOODSON1, and N.S. SOUKOS1, 1Forsyth Institute, Boston, MA, USA, 2OraPharma Inc, Warminster, PA, USA
1147  Susceptibility of oral biofilm bacteria to doxycycline
K. RUGGIERO1, S. DOUCETTE1, A. ABERNETHY1, C. LU1, E. KANASI1, A. TANNER1, J.R. LAWTER2, J.M. GOODSON1, and N.S. SOUKOS1, 1Forsyth Institute, Boston, MA, USA, 2OraPharma Inc, Warminster, PA, USA
1148  Resistance to 6 Antibiotics in Subgingival Isolates from Mexican Subjects
A. ALMAGUER-FLORES, J.Y. MORENO-BORJAS, A. SALGADO-MARTINEZ, M.A. SANCHEZ-REYES, E. ALCANTARA-MARURI, and L.A. XIMENEZ-FYVIE, Universidad Nacional Autonoma de Mexico, Mexico city, Mexico
1149  Mechanical /chemical supragingival plaque control as part of periodontal therapy
M. FAVERI1, S.L. SALVADOR2, L.C. GURSKY1, J.A. SHIBLI1, M. FERES1, and L.C. FIGUEIREDO1, 1University of Guarulhos, Brazil, 2University of Sao Paulo, Ribeirao Preto, SP, Brazil
1150  Non-Surgical Treatment of Chronic Periodontitis Using Photoactivated Disinfection
N. LOEBEL1, R. ANDERSEN1, D. HAMMOND1, S. LEONE2, and V. LEONE2, 1Ondine Biopharma Corporation, Redmond, WA, USA, 2Silver Lake Dental Complex, Everett, WA, USA
1151  Comparison Between Full-mouth Disinfection and Basic Therapy of Aggressive Periodontitis
R.M. MOREIRA, and E.J. FERES-FILHO, Universidade Federal Do Rio De Janiero, Rio de Janeiro, Brazil
1152  WITHDRAWN
1153  CMT-3/Doxycycline Modulate Human Macrophage and PMNL Migration In Vitro
H.-M. LEE1, J. PRICE2, R. KAROLL3, J. CAO1, and L.M. GOLUB1, 1State University of New York - SUNY - Stony Brook, USA, 2University of Pennsylvania, Philadelphia, USA, 3North Shore Heb Acad, Plainview, NY, USA
1154  In-vitro Model for Characterization of NSAID Accumulation by Oral Epithelium
R. FITZGERALD, and J.D. WALTERS, Ohio State University, Columbus, USA
1155  Relation of salivary flow rate to supragingival biofilm species
X. SONG, G. TORRESYAP, A.D. HAFFAJEE, R.P. TELES, and S.S. SOCRANSKY, The Forsyth Institute, Boston, MA, USA
1156  Zinc Chloride/Sodium Chlorite Instability and Its Relation to Oral Malodor
D. CODIPILLY, and I. KLEINBERG, State University of New York - SUNY - Stony Brook, USA
1157  Use of an Optical Detection Sysyem for Detecting Subgingival Calculus
J. MASCARENHAS, S. BLANCHARD, D. NEWELL, B. HANCOCK, M. KOWOLIK, and G. ECKERT, Indiana Universty Purdue University Indianapolis, USA
1158  Subjective intensity of pain during ultrasonic supragingival calculus removal
A. BRAUN, F. KRAUSE, and S. JEPSEN, University of Bonn, Germany
1159  Water flow rate significantly reduces unloaded ultrasonic scaler performance
A.D. WALMSLEY, S. LEA, G. LANDINI, and J. LIGHTSTONE, University of Birmingham, United Kingdom
1160  How ultrasonic scaler performance changes with water loading
S.C. LEA, A.D. WALMSLEY, and G. LANDINI, University of Birmingham, United Kingdom
1161  The Effect of New Needle for Periodontal Pocket Irrigation
J.-I. OTOGOTO, O. NORIO, Y. AKIO, and K. AKIHIRO, Matsumoto Dental University, Shiojiri, Japan
1162  In vitro and in vivo correlation for an α-tocopherol dentifrice
D. MIKSA1, C. WORRELL1, D. BASTIN2, R. RICHTER2, H.M. TRIVEDI1, V.M. BARNES2, P. LAMBERT2, and T. XU2, 1Colgate-Palmolive Co, Piscataway, NJ, USA, 2Colgate-Palmolive Technology Center, Piscataway, NJ, USA
1163  Microbiological Effects of Diode Laser Treatment of Periodontal Pockets
V.I. HARASZTHY, M.M. ZAMBON, S.G. CIANCIO, and J.J. ZAMBON, State University of New York - Buffalo, USA
1164  Initial Study of the Perio ProtectTM Treatment for Periodontal Disease
L.E. WENTZ1, A.M. BLAKE1, D.C. KELLER2, and B.J. SINDELAR2, 1Ohio University, Athens, USA, 2Keller Professional Group PC, St. Louis, MO, USA
1165  Evaluation of Surrogate End Points in a Dog Periodontitis Model
M.E. RYAN1, O.I. CARNU1, J. FARRELL1, R.D. FINKELMAN2, P. CEUPPENS3, and R.A. MACIEWICZ3, 1Stony Brook University, NY, USA, 2AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA, 3AstraZeneca UK, United Kingdom
1166  Periodontists' Considerations of Patient Factors for the Treatment Process
A. PATEL, P.S. RICHARDS, and M.R. INGLEHART, University of Michigan, Ann Arbor, USA
1167  Anxiety, Depression, Stress and Periodontal Treatment - Providers' Perspectives
P.W. KLOOSTRA, R. EBER, and M. INGLEHART, University of Michigan, Ann Arbor, USA

Back to the: Periodontal Research - Therapy Program

Back to the ADEA/AADR/CADR Meeting & Exhibition (March 8-11, 2006)

Top Level Search